EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends in the Resistance to beta-lactams and others antimicrobials in P aeruginosa in Venezuelan medical centres Nosocomial and communitarian resistance



Trends in the Resistance to beta-lactams and others antimicrobials in P aeruginosa in Venezuelan medical centres Nosocomial and communitarian resistance



International Journal of Antimicrobial Agents 19(Supplement 1): S86




(PDF 0-2 workdays service: $29.90)

Accession: 035985571

Download citation: RISBibTeXText



Related references

A 10 year study of resistance of Staphylococcus aureus to selected antimicrobials in three Venezuelan centres. International Journal of Antimicrobial Agents 16(3): 253-253, 2001

Spreading and mechanisms of antibiotic resistance of microorganisms, producing beta-lactamases. Molecular mechanisms of resistance to beta-lactams of Klebsiella spp. strains, isolated in cases of nosocomial infections. Biomeditsinskaia Khimiia 54(1): 104-113, 2008

Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams. Journal of Antimicrobial ChemoTherapy 35(2): 295-304, 1995

Spreading and mechanisms of antimicrobial resistance of microorganisms, producing beta-lactamases. Phenotyping of potential AmpC-beta-lactamases producers of Enterobacteriaceae and molecular mechanisms of resistance to beta-lactams of Enterobacter cloacae strains, isolated in cases of nosocomial infections. Biomeditsinskaia Khimiia 55(1): 50-60, 2009

Effect of beta-lactamase inhibitors on the evolution of resistance to beta-lactams in Gram-Negative bacilli in Venezuelan Hospitals, 1988-19. International Journal of Antimicrobial Agents 19(Supplement 1): S86, 2002

Plasmidic extended spectrum resistance to beta-lactams in nosocomial infections. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 70(12): 1211-1219, 1996

Transferable resistance to beta-lactams in a nosocomial strain of Xanthomonas maltophilia. Antimicrobial Agents and ChemoTherapy 39(4): 1011-1012, 1995

Mechanisms of resistance to beta-lactams in non-aeruginosa Pseudomonas. Abstracts of the General Meeting of the American Society for Microbiology 96(0): 139, 1996

Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams. Antimicrobial Agents and ChemoTherapy 26(4): 485-488, 1984

Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Chemioterapia 4(1): 95-101, 1985

Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams. Pathologie-Biologie 31(5): 387-391, 1983

Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa. Journal of ChemoTherapy 7 Suppl 4: 76-77, 1995

Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections. Expert Review of Anti-Infective Therapy 3(6): 915-922, 2005

Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa. Antimicrobial Agents and ChemoTherapy 43(2): 400-402, 1999

Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease 52(2): 145-151, 2005